Covid-19 vaccine failure in a patient with multiple sclerosis on ocrelizumab

Keyphrases

• Multiple Sclerosis 100%
• COVID-19 Vaccine 100%
• Ocrelizumab 100%
• Vaccine Failure 100%
• Anti-B Cell Therapy 66%
• Immunosuppressive Therapy 33%
• Patient Management 33%
• Vaccine Effectiveness 33%
• Vaccine Response 33%
• Vaccination 33%
• Relapsing-remitting multiple Sclerosis 33%
• COVID-19 Pandemic 33%
• COVID-19 mRNA Vaccine 33%
• Attenuated Vaccine 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Multiple Sclerosis 100%
• Ocrelizumab 100%
• Immunosuppressive Agent 25%
• Infection 25%
• Vaccine 25%
• COVID-19 Vaccine 25%
• Pandemic 25%
• Live Vaccine 25%
• mRNA Vaccine 25%